Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of cataract and refractive surgery

• Publication date

  2012-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jcrs.2012.04.034PMID 22795976
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Topical Ocular Delivery of NSAIDs

  2008cited by this paper
• A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients.

  2008cited by this paper
• Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery

  2008cited by this paper
• Nepafenac 0.1% Compared to Ketorolac 0.5% and Placebo in Cataract Surgery

  2007cited by this paper
• Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery

  2007cited by this paper
• Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation.

  2007cited by this paper
• Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care

  2005cited by this paper
• Postoperative subretinal fluid associated with cystoid macular edema following cataract surgery.

  2005cited by this paper
• Prostaglandins and cystoid macular edema.

  2002cited by this paper
• Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery.

  2001cited by this paper
• Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema.

  2000cited by this paper
• Nepafenac, a Unique Nonsteroidal Prodrug with Potential Utility in the Treatment of Trauma-Induced Ocular Inflammation: II. In Vitro Bioactivation and Permeation of External Ocular Barriers

  2000cited by this paper
• A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells.

  1998cited by this paper
• Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery.

  1998cited by this paper
• Perioperative antibiotic, steroid, and nonsteroidal anti-inflammatory agents in cataract intraocular lens surgery.

  1997cited by this paper
• Comparative results of combined procedures for glaucoma and cataract: I. Extracapsular cataract extraction versus phacoemulsification and foldable versus rigid intraocular lenses.

  1997cited by this paper
• Validation of a questionnaire for comparing the tolerability of ophthalmic medications.

  1997influential reference
• Nonsteroidal anti-inflammatory agents in cataract intraocular lens surgery.

  1995cited by this paper
• Efficacy of diclofenac sodium ophthalmic solution versus placebo in reducing inflammation following cataract extraction and posterior chamber lens implantation

  1994cited by this paper
• Indomethacin in the treatment of postoperative cystoid macular edema.

  1984cited by this paper

• Pseudophakic macular edema: Review and new insights on treatment and prophylaxis.

  2025cites this paper
• Incidence, Pathogenesis, Risk Factors, and Treatment of Cystoid Macula Oedema Following Cataract Surgery: A Systematic Review

  2025influential citation
• Nepafenac role in macular swelling prevention and in visual outcome after cataract surgery – a systematic review and meta-analysis

  2025cites this paper
• Prophylactic regimens for the prevention of pseudophakic cystoid macular edema: systematic review and meta-analysis

  2024cites this paper
• Topical NSAIDs impact on macular oedema and visual outcome after phacoemulsification: systematic review of RCTs with network meta-analysis

  2024cites this paper
• Preparation of Polycaprolactone and Polymethacrylate Nanofibers for Controlled Ocular Delivery of Ketorolac tromethamine: Pharmacokinetic study in Rabbit's Eye.

  2023cites this paper
• Prophylaxis of macular edema after cataract surgery in diabetic patients, topical Nepafenac versus intravitreal Ranibizumab

  2021cites this paper
• Comparison of visual acuity and post-operative inflammation in phacoemulsification and removal of silicone oil with and without injection of Enoxaparin Sodium (40mg/0.04ml)

  2021cites this paper
• ROLE OF TOPICAL NEPAFENAC IN PREVENTING INCREASE IN MACULAR THICKNESS AFTER PHACOEMULSIFICATION

  2021cites this paper
• CENTRAL MACULAR THICKNESS AFTER COMBINED THERAPY OF BEVACIZUMAB INTRAVITREAL INJECTION AND TOPICAL DICLOFENAC COMPARED WITH BEVACIZUMAB INTRAVITREAL INJECTION ALONE IN DIABETIC MACULAR EDEMA

  2021cites this paper
• Macular Alteration of Topical Diclofenac Sodium after Phacoemulsification Surgery in Diabetic Patients

  2021cites this paper
• INHIBITION OF SURGICALLY INDUCED MIOSIS WITH NEPAFENAC

  2021cites this paper
• Nepafenac in cataract surgery

  2021influential citation
• Effect of nepafenac 0.1% on retinal thickness after cataract surgery in patients without risk factors for cystoid macular edema.

  2020cites this paper
• [Pseudophakic cystoid macular edema].

  2020cites this paper
• Post-cataract Cystoid Macular Oedema Prevention – Update 2019

  2019cites this paper
• Topical NSAIDs in Prevention of Postcataract Macular Edema

  2019cites this paper
• Bilateral and symmetric postoperative cystoid macular edema in a patient with macular telangiectasia type 2 after uneventful subsequent phacoemulsification procedures.

  2019cites this paper
• Review of the Evidence for Topical Nonsteroidal Anti-inflammatory Drugs Post-cataract Surgery

  2019cites this paper
• Prevention of macular edema after cataract surgery

  2018cites this paper
• Comparison of macular thickness by optical coherence tomography measurements after uneventful phacoemulsification using ketorolac tromethamine, nepafenac, vs a control group, preoperatively and postoperatively

  2018cites this paper
• Nepafenac in the Treatment of Ocular Inflammation Following Cataract Surgery (Pseudophakic Macular Oedema) – an Update

  2018cites this paper
• Intraindividual comparison of nepafenac 0.3% for the prevention of macular edema after phacoemulsification.

  2018cites this paper
• Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives

  2017cites this paper
• Cataract Combined with Diabetic Non-Proliferative Retinopathy Reduced the Concentration of IL-12 in the Eye with Diclofenac

  2017cites this paper
• Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery.

  2017cites this paper
• 白内障合并糖尿病非增殖性视网膜病变患者术前局部使用双氯芬酸钠降低眼内IL-12浓度 Cataract Combined with Diabetic Non-Proliferative Retinopathy Reduced the Concentration of IL-12 in the Eye with Diclofenac

  2017cites this paper
• Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo

  2017influential citation
• Comparison of the efficacy and patients’ tolerability of Nepafenac and Ketorolac in the treatment of ocular inflammation following cataract surgery: A meta-analysis of randomized controlled trials

  2017cites this paper
• Efficacy of nepafenac ophthalmic suspension 0.1% in improving clinical outcomes following cataract surgery in patients with diabetes: an analysis of two randomized studies

  2017cites this paper
• Prostaglandin E2 Levels of Aqueous and Vitreous Humor in Ketorolac 0.4% and Nepafenac 0.1% Administered Healthy Rabbits

  2017cites this paper
• Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery.

  2016cites this paper
• One-Day Use of Preoperative Topical Nonsteroidal Anti-Inflammatory Drug Prevents Intraoperative Prostaglandin Level Elevation During Femtosecond Laser-Assisted Cataract Surgery

  2016influential citation
• The Effect of Prophylactic Nepafenac 0.1% Eye Drops on Macular Changes after Phacoemulsification in Non- Proliferative Diabetic Retinopathy Patients Using Spectral Domain Optical Coherence Tomography (SD-OCT)

  2016cites this paper
• Macular assessment using Optical Coherence Tomography in patients after uneventful phacoemulsification treated postoperatively with bromfenac, diclofenac or dexamethasone.

  2016cites this paper
• Topical NSAIDs Effect on Corneal Sensitivity

  2015cites this paper
• Profilaxia e tratamento do edema macular cistoide após cirurgia de catarata Prophylaxis and treatment of cystoid macular edema after cataract surgery

  2015cites this paper
• Prospective, Randomized Study Comparing the Effect of 0.1% Nepafenac and 0.4% Ketorolac Tromethamine on Macular Thickness in Cataract Surgery Patients With Low Risk for Cystoid Macular Edema

  2015cites this paper
• Re: Kessel et al.: post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review (Ophthalmology 2014;121:1915-24).

  2015cites this paper
• Topical Nonsteroidal Anti-inflammatory Drugs and Cataract Surgery: A Report by the American Academy of Ophthalmology.

  2015cites this paper
• TOPICAL NEPAFENEC IN EYES WITH NONCENTRAL DIABETIC MACULAR EDEMA

  2015cites this paper
• Post-cataract Prevention of Inflammation and Macular Edema by Steroid and Nonsteroidal Anti-inflammatory Eye Drops: A Systematic Review

  2015cites this paper
• Prevention of Cystoid Macular Edema After Cataract Surgery in Nondiabetic and Diabetic Patients: A Systematic Review and Meta-Analysis.

  2015cites this paper
• Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review.

  2014cites this paper
• Non steroidal anti-inflammatory drugs in the prevention of cystoid macular edema after uneventful cataract surgery

  2014cites this paper
• Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study

  2014cites this paper
• Levels of Selected Aqueous Humor Mediators (IL-10, IL-17, CCL2, VEGF, FasL) in Diabetic Cataract

  2014cites this paper
• Prophylactic Use of Ketorolac Tromethamine in Cataract Surgery: A Randomized Trial

  2014influential citation
• Topical Nonsteroidal Anti-Inflammatory Drugs for Macular Edema

  2013cites this paper
• Randomized Placebo-Controlled Double-Masked Prospective Studies in Aphakic Eyes

  year unknowncites this paper
• Effect of 0.1% Nepafenac Eye Drops on Macular Thickness After Uneventful Phacoemulsification Assessed By Optical Coherence Tomography

  year unknowncites this paper
• Clinical Interventions in Aging Dovepress Pseudophakic Cystoid Macular Edema: Update 2016

  year unknowncites this paper